Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00705315
What this trial is testing

Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 46
Testing effectiveness (Phase 2)WithdrawnNCT00988897
What this trial is testing

Colorectal Cancer RECHALLENGE

Who this might be right for
Colorectal Neoplasms
Sanofi
Large-scale testing (Phase 3)Ended earlyNCT04428333
What this trial is testing

Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Neoplasms, Head and Neck
GlaxoSmithKline 117
Large-scale testing (Phase 3)Study completedNCT03594747
What this trial is testing

Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BeiGene 360
Testing effectiveness (Phase 2)Looking for participantsNCT06885385
What this trial is testing

Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06557889
What this trial is testing

Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Institut Claudius Regaud 86
Testing effectiveness (Phase 2)UnknownNCT03240549
What this trial is testing

Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable Disease

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Beijing Hospital 159
Testing effectiveness (Phase 2)Looking for participantsNCT06469944
What this trial is testing

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Who this might be right for
Gastroesophageal JunctionGastroesophageal AdenocarcinomaEsophageal Neoplasms+1 more
Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)Study completedNCT00517595
What this trial is testing

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Accelerated Community Oncology Research Network 48
Testing effectiveness (Phase 2)UnknownNCT06403111
What this trial is testing

FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Changzhou No.2 People's Hospital 62
Large-scale testing (Phase 3)Active Not RecruitingNCT05984277
What this trial is testing

A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.

Who this might be right for
Metastatic Non-small Cell Lung Cancer
AstraZeneca 895
Large-scale testing (Phase 3)Study completedNCT02546934
What this trial is testing

ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
Fudan University 254
Not applicableEnded earlyNCT04698681
What this trial is testing

NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerNon-Squamous Non-Small Cell Neoplasm of Lung+3 more
Calithera Biosciences, Inc 20
Testing effectiveness (Phase 2)Study completedNCT00350792
What this trial is testing

Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 62
Large-scale testing (Phase 3)Looking for participantsNCT06764875
What this trial is testing

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

Who this might be right for
HER2-positive Gastric CancerGastroesophageal Junction Adenocarcinoma
AstraZeneca 840
Testing effectiveness (Phase 2)UnknownNCT05585281
What this trial is testing

Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Who this might be right for
Ovarian Cancer
Yongpeng Wang 25
Large-scale testing (Phase 3)Looking for participantsNCT07170995
What this trial is testing

Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Advanced or Metastatic Non-small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 460
Large-scale testing (Phase 3)Active Not RecruitingNCT03043872
What this trial is testing

Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)

Who this might be right for
Small Cell Lung Carcinoma Extensive Disease
AstraZeneca 987
Large-scale testing (Phase 3)Looking for participantsNCT06989112
What this trial is testing

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Who this might be right for
Endometrial Cancer
AstraZeneca 600
Testing effectiveness (Phase 2)Looking for participantsNCT06463665
What this trial is testing

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Who this might be right for
Advanced Non-squamous Non-small-cell Lung CancerAdvanced Squamous Non-Small Cell Lung CarcinomaMetastatic Non-squamous Non Small Cell Lung Cancer+5 more
Genelux Corporation 142
Next Page